Perspectives on sipuleucel-T: Its role in the prostate cancer treatment paradigm

Sipuleucel-T is an autologous cellular immunotherapy approved in the US for patients with asymptomatic or minimally symptomatic metastatic castration-resistant prostate cancer (mCRPC). This significant advance for mCRPC treatment provides healthcare professionals with another effective therapy to ex...

Descripción completa

Detalles Bibliográficos
Autores principales: Gulley, James L., Mulders, Peter, Albers, Peter, Banchereau, Jacques, Bolla, Michel, Pantel, Klaus, Powles, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4839373/
https://www.ncbi.nlm.nih.gov/pubmed/27141392
http://dx.doi.org/10.1080/2162402X.2015.1107698

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4839373/
https://www.ncbi.nlm.nih.gov/pubmed/27141392
http://dx.doi.org/10.1080/2162402X.2015.1107698

Ejemplares similares